Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.

Over 11,000 bottles are being pulled from shelves after testing revealed a manufacturing error that introduced trace amounts ...

These chemicals—including acrylamide—have been linked to health risks and are found in a wide array of popular foods. Here's ...

Pet owners are increasingly cognizant of the link between nutrition and pet health, leading to a heightened demand for specialized pet food products. Diseases like obesity, diabetes, and arthritis ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

Kazia Therapeutics Limited ("Kazia" or the "Company")  today announced new data from two presentations at the 2025 San Antonio Breast Cancer Symposium (SABCS) providing compelling mechanistic and ...

The investigation shows how profit-driven psychiatry and compromised regulators created a crisis of violence masked as ...

The FDA's proposed rule would require food manufacturers to put "Nutrition Info" boxes on the front of their packages stating ...